Skip to main content

Beauty Health Co

For the period ended Mar 31, 2024. Filed May 9, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 9, 2024

SKIN$15.94-4.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(in thousands, except for share amounts)

Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
BALANCE, December 31, 2022132,214,695$14$550,320$(4,530)$(378,751)$167,053
Net loss————(20,259)(20,259)
Issuance of Common Stock pursuant to equity compensation plan473,049—————
Shares withheld for tax withholdings on vested stock awards(170,415)—(2,195)——(2,195)
Issuance of Common Stock relating to employee stock purchase plan——2,034——2,034
Share-based compensation——3,577——3,577
Common Stock relating to asset acquisition109,625—1,310——1,310
Foreign currency translation adjustment———888—888
BALANCE, March 31, 2023132,626,954$14$555,046$(3,642)$(399,010)$152,408
BALANCE, December 31, 2023122,899,002$12$541,281$(3,036)$(478,867)$59,390
Net loss————(679)(679)
Issuance of Common Stock pursuant to equity compensation plan843,950—————
Shares withheld for tax withholdings on vested stock awards(289,533)—(1,005)——(1,005)
Share-based compensation——6,636——6,636
Foreign currency translation adjustment———(1,047)—(1,047)
BALANCE, March 31, 2024123,453,419$12$546,912$(4,083)$(479,546)$63,295
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.